VAMP7: A Potential Drug Target and Biomarker (G6845)

Target Name: VAMP7

NCBI ID: G6845

VAMP7

VAMP7: A Potential Drug Target and Biomarker

VAMP7, or VAM-P7, is a protein that is expressed in various tissues and cells throughout the body. It is a member of the VAM family, which includes proteins that are involved in the regulation of cell growth, differentiation, and survival. The discovery of VAMP7 and its potential as a drug target or biomarker has significant implications for the development of new treatments for various diseases.

The VAMP7 protein is known for its role in the regulation of cell proliferation and differentiation. It is a key regulator of the cell cycle, helping to control the number of cells that divide and the process by which they differentiate into specialized cells. In addition, VAMP7 is involved in the regulation of cell survival, working to ensure that cells live long enough to perform their necessary functions before they are replaced.

The identification of VAMP7 as a potential drug target is based on its unique structure and the various functions that it plays in the body. One of the key reasons for its potential as a drug target is its high degree of cross-talk, or the ability of one protein to interact with multiple others. This allows drugs to target VAMP7 and have a more targeted effect on the cell.

In addition to its role in cell regulation, VAMP7 has also been shown to play a key role in the development and progression of various diseases. For example, studies have shown that VAMP7 is expressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that targeting VAMP7 may be a promising strategy for the development of new treatments for these diseases.

Furthermore, VAMP7 has also been shown to be involved in the regulation of cellular processes that are important for brain function, such as the regulation of neurotransmitter release and the maintenance of cellular stability. This suggests that VAMP7 may also be a promising target for the development of new treatments for neurological disorders.

In conclusion, the discovery of VAMP7 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. With its unique structure and various functions, VAMP7 has the potential to be a valuable tool for the development of new treatments for a wide range of conditions. Further research is needed to fully understand the potential of VAMP7 as a drug target and biomarker, and to develop safe and effective treatments for the various diseases that it is involved in.

Protein Name: Vesicle Associated Membrane Protein 7

Functions: Involved in the targeting and/or fusion of transport vesicles to their target membrane during transport of proteins from the early endosome to the lysosome. Required for heterotypic fusion of late endosomes with lysosomes and homotypic lysosomal fusion. Required for calcium regulated lysosomal exocytosis. Involved in the export of chylomicrons from the endoplasmic reticulum to the cis Golgi. Required for exocytosis of mediators during eosinophil and neutrophil degranulation, and target cell killing by natural killer cells. Required for focal exocytosis of late endocytic vesicles during phagosome formation

The "VAMP7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VAMP7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets